Company overview

Outset Medical supplies healthcare providers with Tablo, a system for blood-filtering treatment known as hemodialysis. Its compact console purifies tap water and makes dialysis fluid as needed. The company sells primarily directly to U.S. customers, with hospitals its main focus, and helps hospitals run dialysis themselves rather than outsource it. Tablo is also cleared for use in clinics and patients’ homes.

Customers buy a console up front, then purchase disposable Tablo cartridges for treatments and service agreements covering maintenance, repairs, training, cloud connectivity and software updates. Consumables are the largest revenue line; together, consumables and services bring in more revenue than new consoles and accessories. Nearly all revenue is tied to Tablo, and the largest customer accounts for a meaningful share of sales.

The business depends on providers buying more consoles and continuing to use those already installed. Hospital capital budgets affect equipment purchases, while dialysis reimbursement, including Medicare payments, influences what customers can afford to pay. Home expansion also depends on providers establishing programs and training patients. Outset must keep its devices compliant with FDA requirements, cannot promote uses outside cleared indications, and may need new regulatory clearance or approval for product changes.